Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
EPLIVANSERIN
Not marketed
Insomnia
EFC10844ECLIPSEEudraCT: 2008-003791-22Summary Results
EPLIVANSERIN
Not marketed
Sleep disorders
EFC6220EPOCHNCT00308503Summary
EPLIVANSERIN
Not marketed
Sleep disorders
LTE6217GEMSEudraCT: 2005-003080-23Summary Results
EPLIVANSERIN
Not marketed
Sleep disorders
LTE6262EPLILONGEudraCT: 2005-003082-16Summary Results
EPLIVANSERIN
Not marketed
Sleep disorders
PKD10491PKiDsNCT00913614Summary
EZETIMIBE + ROSUVASTATIN CALCIUM
Zenon Neo
Hypercholesterolaemia
LPS15021ZENONEudraCT Number: 2016-004556-30Tabulated Results
FATTY ACID AMIDE HYDROLASE INHIBITOR
Not marketed
Cancer pain
ACT11705NAEudraCT: 2011-002557-56Summary Results
FATTY ACID AMIDE HYDROLASE INHIBITOR
Not marketed
Major Depressive Disorder
DFI10560FIDELIOEudraCT: 2008-001718-26Summary Results
FEDRATINIB- No longer a Sanofi product
NA
Hematopoietic Neoplasm
ARD11936NANCT01420770NA
FEDRATINIB- No longer a Sanofi product
NA
Hematopoietic Neoplasm
ARD12042NANCT01420783NA

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted